Has Maykol Postigo Jasahui, MD received payments from drug or device companies?

Yes. Drug and device makers reported $321,869 in general payments to Maykol Postigo Jasahui, MD across 459 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Maykol Postigo Jasahui, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Maykol Postigo Jasahui, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Maykol Postigo Jasahui, MD

Pulmonary Disease · Kansas City, KSNPI 1023305661

Payments from drug & device makers

What this record shows

This record is dominated by education: $204,875 of the $321,869 with a category attached, or 63.7%. Intuitive Surgical accounts for 96.4% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $190,179, more than ten times the $3,359 reported in 2019. Among pulmonary disease clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$321,869in general payments, 2019–2025

Across 459 payments — averaging $701.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$310K
Johnson & Johnson$2K
Pinnacle Biologics, Inc$2K
Pulmonx Corporation$2K
Boehringer Ingelheim$1K
Olympus America Inc.$1K
plus $3K from 7 others

What the payments were for

Consulting fees$2,0301%
Speaking & faculty fees$55,75017%
Travel & lodging$37,05512%
Food & beverage$22,0877%
Education$204,87564%
Gifts$720%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	388	$310,391
Johnson & Johnson	14	$2,261
Pinnacle Biologics, Inc	10	$2,217
Pulmonx Corporation	12	$1,865
Boehringer Ingelheim	1	$1,300
Olympus America Inc.	13	$1,139
Veran Medical Technologies, Inc.	14	$993
Cook Incorporated	1	$750
Olympus Corporation	1	$730
La Jolla Pharmaceutical Company	1	$120
Boston Scientific	1	$44
Ambu Inc.	2	$34
Olympus Corporation Of The Americas	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Da Vinci Surgical System$296,577
DA VINCI SP$10,300
Photofrin$1,796
OFEV$1,300
Pulmonx Endobronchial Valve EBV$1,135
Monarch Platform$961
Spin$811
MONARCH$800
CHARTIS CATHETER$503
ZEPHYR DELIVERY CATHETER$503
ZEPHYR ENDOBRONCHIAL VALVE$503
PULMONX CHARTIS TABLET CONSOLE$503
Spiration Valve System$422
ENDOCAPSULE SMALL INTESTINAL CAPSULE ENDOSCOPE SET??$416
SPiN Thoracic Navigation System, 120V, 60Hz$298
ION$206
Olympus$151
EVIS EXERA III BRONCHOVIDEOSCOPE$151
GIAPREZA$120

How this compares

$321,869 in reported general payments places this provider in the 95th percentile of 92 pulmonary disease providers in Kansas.

See all pulmonary disease providers in Kansas →

Medicare billing

Part B allowed, 2024

$91,715

Medicare patients

232

Services billed

725

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate	21	$696

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Kansas City

Mario CastroKansas City$1.9M
Matthew SharpeKansas City$602K
Chase HallKansas City$329K
Andreas SchmidKansas City$26K
Harold BarkmanKansas City$24K
Heath LathamKansas City$15K
Kyle BrownbackKansas City$15K
Michelle HomanKansas City$8K
Aman KhanKansas City$5K
Damien StevensKansas City$3K

See the full list for Kansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →